These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

116 related articles for article (PubMed ID: 6619031)

  • 1. The tolerance and safety of azlocillin.
    Parry MF
    J Antimicrob Chemother; 1983 May; 11 Suppl B():223-8. PubMed ID: 6619031
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The safety and tolerance of azlocillin.
    Parry MF
    Arzneimittelforschung; 1985; 35(8):1292-4. PubMed ID: 4074446
    [TBL] [Abstract][Full Text] [Related]  

  • 3. International clinical experience with azlocillin.
    Schacht P; Arcieri G; Bruck H; Griffith E; Hullman R; Tettenborn D
    J Antimicrob Chemother; 1983 May; 11 Suppl B():215-22. PubMed ID: 6619030
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A comparison of azlocillin and ticarcillin in the treatment of complicated urinary tract infections.
    Cox CE
    J Antimicrob Chemother; 1983 May; 11 Suppl B():183-8. PubMed ID: 6352601
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparative clinical evaluation of azlocillin and gentamicin.
    Sabbaj J; Torres M; Loza L
    J Antimicrob Chemother; 1983 May; 11 Suppl B():175-81. PubMed ID: 6619027
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The use of azlocillin to treat serious infections.
    Neu HC; Francke EL; Ortiz-Neu C; Prince AS
    J Antimicrob Chemother; 1983 May; 11 Suppl B():141-7. PubMed ID: 6619023
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A comparative study of the efficacy and safety of azlocillin and gentamicin in the treatment of serious infections.
    del Rosal PL
    J Antimicrob Chemother; 1983 May; 11 Suppl B():159-67. PubMed ID: 6352599
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparative efficacy and tolerance study of azlocillin and carbenicillin in patients with cystic fibrosis: a double blind study.
    Huang NN; Palmer J; Keith H; Schidlow D; Braverman S; Goldberg M
    J Antimicrob Chemother; 1983 May; 11 Suppl B():205-14. PubMed ID: 6352603
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparison of azlocillin and ticarcillin in the treatment of urinary tract infection.
    Reed WP; Palmer DL
    J Antimicrob Chemother; 1983 May; 11 Suppl B():189-93. PubMed ID: 6619028
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Clinical results with azlocillin (author's transl)].
    Schacht P; Tettenborn D; Hullmann R; Bruck H
    Arzneimittelforschung; 1979; 29(12a):1981-5. PubMed ID: 396929
    [No Abstract]   [Full Text] [Related]  

  • 11. An evaluation of the safety and tolerance of Timentin.
    Croydon EA; Hermoso C
    J Antimicrob Chemother; 1986 May; 17 Suppl C():233-40. PubMed ID: 3722045
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Evaluation of the clinical activity of azlocillin. A multicenter study conducted in 14 centers].
    Konopka CA
    Presse Med; 1984 Mar; 13(13):808-11. PubMed ID: 6231600
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Clinical experience with azlocillin in the treatment of urinary tract infections with Pseudomonas aeruginosa.
    Vestin L; Burman LA; Holm S; Sellers J
    Scand J Infect Dis; 1982; 14(4):289-91. PubMed ID: 7163781
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Azlocillin treatment of urinary tract infection in patients on haemodialysis.
    Hallan H; Svarva PL; Svartås TM; Widerøe T
    Scand J Infect Dis Suppl; 1981; 29():55-8. PubMed ID: 6947406
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Adverse effects of antibiotics.
    Cunha BA; Ristuccia AM
    Heart Lung; 1984 Sep; 13(5):465-72. PubMed ID: 6236175
    [No Abstract]   [Full Text] [Related]  

  • 16. Azlocillin in respiratory tract infections with Pseudomonas aeruginosa in children with cystic fibrosis.
    Michalsen H; Bergan T
    Chemotherapy; 1980; 26(2):135-40. PubMed ID: 7363708
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Azlocillin treatment of Pseudomonas aeruginosa bronchopulmonary infections in children with cystic fibrosis].
    Grenier B; Gilly R
    Presse Med; 1984 Mar; 13(13):815-8. PubMed ID: 6231602
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Randomized, double-blind evaluation of azlocillin for the treatment of pulmonary exacerbations of cystic fibrosis.
    McLaughlin FJ; Matthews WJ; Strieder DJ; Sullivan B; Goldmann DA
    J Antimicrob Chemother; 1983 May; 11 Suppl B():195-203. PubMed ID: 6352602
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Experiences using acylureido-penicillins (azlocillin, mezlocillin) in pediatrics].
    Weingärtner L; Sitka U; Patsch R; Thiemann HH
    Klin Padiatr; 1984; 196(1):28-35. PubMed ID: 6694339
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Treatment of serious Pseudomonas infections with azlocillin.
    Olive S; Mogabgab WJ; Holmes B; Pollock B; Pauling B; Beville R
    J Antimicrob Chemother; 1983 May; 11 Suppl B():153-8. PubMed ID: 6619026
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.